Atorvastatina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Atorvastatina" in Spanish language version.

refsWebsite

Global rank Spanish rank

3ama-assn.org

3,257^th place

2,610^th place

3nejm.org

2,374^th place

1,798^th place

3nih.gov

4^th place

2web.archive.org

1^st place

1agemed.es

low place

1sciencedirect.com

149^th place

128^th place

1cardiab.com

low place

1annals.org

low place

6,230^th place

1fda.gov

447^th place

668^th place

agemed.es

sinaem4.agemed.es

Ministerio de Sanidad y Política Social. «Ficha técnica atorvastatina». Agencia Española del Medicamento y Productos Sanitarios. Consultado el 14 de noviembre de 2010. (enlace roto disponible en Internet Archive; véase el historial, la primera versión y la última).

ama-assn.org

jama.ama-assn.org

Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters, et al.. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study Investigators. The effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled study. JAMA 2001;285:1711-8.
Steven E. Nissen; E. Murat Tuzcu, et al. for the REVERSAL Investigators Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis. A Randomized Controlled Trial JAMA. 2004;291:1071-1080.
Pedersen,TR.; Faergeman, O. et al. for the IDEAL study group. High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction. JAMA. 2005;294:2437-2445. Disponible en http://jama.ama-assn.org/cgi/content/full/294/19/2437

annals.org

David H. Blankenhorn; Stanley P et al. The MARS Research Group. Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS). Annals of Internal Medicine. 1993. Volume 119 Issue 10. Pages 969-976

cardiab.com

Berne,C and Siewert,A for the URANUS study investigators. Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study. Cardiovascular Diabetology 2005, 4:7 Disponible en http://www.cardiab.com/content/4/1/7

fda.gov

http://www.fda.gov/drugs/drugsafety/ucm293101.htm

nejm.org

content.nejm.org

Cannon CP, Braunwald E, et al, for the Pravastatin or Atorvastatin Evaluation and Infection therapy-Thrombolysis in myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1.495-504 Disponible en http://content.nejm.org/cgi/content/abstract/350/15/1495
LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al, for the Treating to New Targets (TNT) investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35
Pitt B, Waters D, et al. Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease. N Engl J Med 1999;341:70

nih.gov

ncbi.nlm.nih.gov

Schwartz JB (February 2009). "Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence". Clin. Pharmacol. Ther. 85 (2): 198–203. doi:10.1038/clpt.2008.165. PMID 18754003.
Kane GC, Lipsky JJ (September 2000). "Drug-grapefruit juice interactions". Mayo Clinic Proceedings 75 (9): 933–42. doi:10.4065/75.9.933. PMID 10994829.

pubmedcentral.nih.gov

Zheng Zhou, Elham Rahme et al. Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.CMAJ. 2005 April 26; 172(9): 1187–1194. Disponible en http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=557070

sciencedirect.com

Stalenhoef AFH, Ballantyne CM, Sarti, C et al. A Comparative study with rosuvastatin in subjects with METabolic Syndrome: rationale and design of the COMETS study. Archivado el 11 de febrero de 2009 en Wayback Machine. Diabetes Metab 2003;29(Suppl): 4S318 Abstract 2559.

web.archive.org

Ministerio de Sanidad y Política Social. «Ficha técnica atorvastatina». Agencia Española del Medicamento y Productos Sanitarios. Consultado el 14 de noviembre de 2010. (enlace roto disponible en Internet Archive; véase el historial, la primera versión y la última).
Stalenhoef AFH, Ballantyne CM, Sarti, C et al. A Comparative study with rosuvastatin in subjects with METabolic Syndrome: rationale and design of the COMETS study. Archivado el 11 de febrero de 2009 en Wayback Machine. Diabetes Metab 2003;29(Suppl): 4S318 Abstract 2559.